MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology _ Gene Editing, CRISPR, Etc.
Akribion Therapeutics
Organization & Developments: Akribion Therapeutics
Parents
Akribion Therapeutics
Children
* Ensures only targeted cells are affected, leaving healthy cells unharmed
*Developing RNA-guided, nuclease-based technology for programmable cell depletion
*Gene editing platform can kill cells by shredding DNA and RNA, but only if there is a highly specific match between the guide RNA and an intracellular RNA sequence
2026: New Kind of CRISPR Could Treat Viral Infection and Cancer by Shredding Sick Cells’ DNA
2026: Next Generation CRISPR Gene Editing Could Help Target Cancer Cells
Jumps
Finance & Acquisitions: Akribion Therapeutics
Key People: Akribion Therapeutics